Clinical Trial Update: Biktarvy for Non-Occupational Post-Exposure Prophylaxis (nPEP) [Phase 4]

View source ↗

Summary

Phase 4 trial update for Biktarvy used as non-occupational post-exposure prophylaxis (nPEP) in HIV prevention; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• HIV Prevention

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: Fenway Community Health | Conditions: HIV Prevention | Phase 4 | Status: COMPLETED